Diflunisal

Medically Reviewed By

Mr. Jitendra K Das M.Pharma • Pharmacology Jitendra K Das is a qualified pharmacist (M.Pharma-Pharmacology) with 9+ years of experience in hospital pharmacy and occupational healthcare. Currently working as Cluster Head in a leading Healthcare sector, he specializes in medication management, patient safety, and clinical support services.

This article has been medically reviewed for accuracy, clinical relevance, and evidence-based medical information.

Last medically reviewed: September 21, 2026

What Is Diflunisal?

Diflunisal is a prescription medicine used to relieve pain and reduce inflammation. It belongs to a class of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Chemically, it is derived from salicylic acid, giving it a structural relationship to other salicylates.

By blocking specific enzymes in the body (cyclooxygenases), Diflunisal decreases the production of prostaglandins—chemicals responsible for promoting pain, swelling, and inflammation. While it shares a chemical lineage with aspirin (acetylsalicylic acid), Diflunisal is fundamentally different from aspirin. It does not permanently inhibit platelets, and it cannot be used as a substitute for low-dose aspirin prescribed for cardiovascular protection.

Diflunisal vs Aspirin

Diflunisal is often confused with aspirin due to its chemical classification, but their clinical roles are strictly distinct.

Attribute	Diflunisal	Aspirin
Chemical Structure	Difluorophenyl derivative of salicylic acid	Acetyl derivative of salicylic acid
Drug Classification	Prescription NSAID / Salicylate derivative	OTC/Prescription NSAID / Salicylate
COX Inhibition	Reversible, competitive inhibition	Irreversible inhibition (acetylation)
Platelet Effects	Reversible, dose-dependent, temporary	Irreversible for the lifespan of the platelet (7-10 days)
Analgesic / Anti-inflammatory	High potency, longer duration	High potency, shorter duration
Antipyretic Effects	Minimal clinically useful antipyretic effect	Strong antipyretic (fever-reducing) effect
Half-Life	8 to 12 hours (dose-dependent)	~15-20 minutes (parent drug), 2-3 hours (salicylate)
Cardiovascular Prevention	None. May increase cardiovascular risk.	Established baseline therapy for secondary prevention.

Important Distinction: Aspirin irreversibly disables the COX-1 enzyme in platelets, permanently preventing them from clumping together for their entire lifespan. Diflunisal only temporarily and reversibly affects platelets. Do not suggest, assume, or use Diflunisal as a replacement for prescribed aspirin used for cardiovascular protection.

Diflunisal vs Other NSAIDs

Attribute	Diflunisal	Ibuprofen	Naproxen	Aspirin
Drug Class	NSAID (Salicylate)	NSAID (Propionic acid)	NSAID (Propionic acid)	NSAID (Salicylate)
Half-Life	8–12 hours	2 hours	12–17 hours	2–3 hours (as salicylate)
Analgesic Activity	Strong	Strong	Strong	Moderate to Strong
Anti-inflammatory	Strong	Moderate to Strong	Strong	Strong
Antipyretic Activity	Minimal	Strong	Strong	Strong
Platelet Effects	Reversible	Reversible	Reversible	Irreversible
Typical Dosing	Twice daily (BID)	Every 4-6 hours	Twice daily (BID)	Every 4-6 hrs (pain) or once daily (CV)
Cardiovascular Risk	Increased risk	Increased risk	Increased risk (possibly lowest)	Protective (low dose)
GI Risk	High	Moderate	High	High

Chemical Information & Composition

• Chemical Name: 2′,4′-difluoro-4-hydroxybiphenyl-3-carboxylic acid
• Molecular Formula: C₁₃H₈F₂O₃
• Molecular Weight: 250.20 g/mol
• Chemical Class: Salicylic acid derivative
• Structural Relationship: It is a difluorophenyl derivative of salicylic acid. The addition of the difluorophenyl group enhances its anti-inflammatory potency and significantly prolongs its half-life compared to un-modified salicylates.

Diflunisal Composition

• Active Ingredient: Diflunisal
• Available Strengths: 250 mg, 500 mg (Availability varies by global region; currently available primarily as generics).
• Dosage Form: Oral film-coated tablets.
• Combination Products: Diflunisal is generally formulated as a single-ingredient product. Do not assume any combination unless verified by official regional labeling.

Dosage Forms and Routes

Dosage Form	Route	Strength	Typical Role
Tablet	Oral	250 mg	Maintenance dosing for osteoarthritis / rheumatoid arthritis
Tablet	Oral	500 mg	Acute pain loading/maintenance, severe arthritis symptoms

Drug Classification & Mechanism of Action

Diflunisal is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and a non-opioid analgesic. While it is a salicylate-derived medicine, its pharmacological profile mirrors modern NSAIDs more closely than traditional aspirin.

For the General Reader:

When your body is injured or experiences arthritis flare-ups, it produces chemicals called prostaglandins. These chemicals cause swelling, redness, and pain. Diflunisal blocks the enzymes (COX-1 and COX-2) that make these chemicals, effectively turning down the volume on pain and reducing joint swelling.

For the Healthcare Professional:

Diflunisal acts by competitively and reversibly inhibiting cyclooxygenase (COX-1 and COX-2) enzymes. This inhibition prevents the conversion of arachidonic acid to pro-inflammatory prostaglandins (PGE2, PGI2) and thromboxanes (TXA2).

• Peripheral vs Central: Its analgesic effect is primarily peripheral, reducing the sensitization of nociceptors to pain mediators like bradykinin, though some central mechanisms may exist.
• COX Relationship to Adverse Effects: Reversible COX-1 inhibition in the gastric mucosa impairs the production of cytoprotective prostaglandins, directly causing its GI toxicity. Inhibition of renal prostaglandins alters renal hemodynamics, leading to fluid retention and potential acute kidney injury.

Pharmacodynamics & Pharmacokinetics

Pharmacodynamics:

• Analgesic & Anti-inflammatory: Highly effective for musculoskeletal pain and joint inflammation.
• Antipyretic: Lacks clinically significant fever-reducing properties compared to other NSAIDs.
• Platelet Function: Reversibly inhibits platelet aggregation. Function returns to normal shortly after the drug is cleared, unlike aspirin.
• Cardiovascular: Causes sodium and water retention by blocking renal prostaglandins, potentially exacerbating hypertension or heart failure.

Pharmacokinetics:

• Absorption: Rapidly and completely absorbed following oral administration. Peak plasma concentrations occur between 2 to 3 hours.
• Distribution: Highly bound to plasma proteins (>99%).
• Metabolism: Hepatic. Metabolized to glucuronide conjugates (ether and ester glucuronides). It undergoes enterohepatic circulation, which prolongs its systemic presence.
• Elimination: Primarily renal excretion of the glucuronide metabolites.
• Half-Life: 8 to 12 hours. The pharmacokinetics are concentration-dependent (capacity-limited). As doses increase, the half-life extends, leading to potential accumulation with repeated dosing.
• Renal Impairment: Metabolite clearance is significantly delayed in renal failure, requiring careful dosage reduction.

Uses and Indications

Diflunisal is indicated for the acute or long-term symptomatic treatment of specific inflammatory and pain conditions.

Diflunisal for Osteoarthritis

Used for symptomatic relief of joint pain, stiffness, and inflammation associated with osteoarthritis. Clinical Limitation: Diflunisal may relieve the symptoms of osteoarthritis but does not reverse, halt, or slow the underlying structural degeneration of the cartilage and bone.

Diflunisal for Rheumatoid Arthritis

Provides symptomatic pain relief and reduction of inflammatory joint swelling. Clinical Limitation: It is exclusively a symptomatic treatment. It does not alter the disease course and does not replace Disease-Modifying Antirheumatic Drugs (DMARDs) or biologic therapies which prevent joint destruction.

Diflunisal for Acute Pain

Indicated for the management of mild-to-moderate acute pain (e.g., musculoskeletal strains, post-operative dental pain). Clinical Limitation: Due to its longer onset of action compared to rapid-acting agents like ibuprofen, the initial loading dose is critical. It should be used at the lowest effective dose for the shortest duration necessary to limit GI and CV risks.

Dosage and Administration

Always verify dosages against local official labeling. Doses below reflect standard FDA/regulatory guidelines.

Indication	Initial Dose	Maintenance Dose	Maximum Dose	Route
Mild to Moderate Acute Pain (Adults)	1000 mg	500 mg every 12 hours (or every 8 hours if needed)	1500 mg / day	Oral
Osteoarthritis (Adults)	250 mg or 500 mg twice daily	500 mg to 1000 mg daily in two divided doses	1500 mg / day	Oral
Rheumatoid Arthritis (Adults)	250 mg or 500 mg twice daily	500 mg to 1000 mg daily in two divided doses	1500 mg / day	Oral

Dosing Principles:

• Use the lowest effective dose for the shortest appropriate duration.
• Swallow tablets whole; do not crush or chew.
• Take with food, milk, or a full glass of water to minimize gastric irritation.
• Avoid duplicate NSAID therapy (do not take with over-the-counter ibuprofen or naproxen).

Renal Impairment:

Dosage reduction is strictly required. While specific protocols vary, standard guidance indicates extending the dosing interval or significantly reducing the dose in moderate impairment. In severe renal impairment, NSAIDs are generally avoided or contraindicated.

Hepatic Impairment:

Monitor closely. Because Diflunisal is extensively bound to plasma proteins and metabolized in the liver, severe hepatic disease alters its pharmacokinetics and increases the risk of bleeding.

Missed Dose & Overdose

Missed Dose: Take the missed dose as soon as remembered according to product instructions. If it is almost time for the next scheduled dose, skip the missed dose. Do not double the dose to make up for a missed one.

Diflunisal Overdose:

Suspected overdose requires urgent medical evaluation in an emergency department.

• Symptoms: Nausea, vomiting, severe abdominal pain, GI bleeding, drowsiness, dizziness, tinnitus (ringing in ears), acute renal failure, and coma.
• Action: No home treatment is safe. Contact emergency services or poison control immediately.

Side Effects & Serious Reactions

A. Common Side Effects

Nausea, dyspepsia (indigestion), abdominal pain, diarrhea, constipation, headache, dizziness, and mild fluid retention (edema).

B. Serious Adverse Reactions (Urgent Medical Attention Required)

• GI Bleeding: Black/tarry stools, vomiting blood, severe abdominal pain.
• Cardiovascular: Chest pain, sudden weakness, shortness of breath, slurred speech (signs of MI or stroke).
• Renal Toxicity: Drastic reduction in urine output, sudden unexplained weight gain, severe swelling of legs/ankles.
• Hypersensitivity: Facial/throat swelling, breathing difficulties, severe skin rashes, blistering, or peeling (Stevens-Johnson Syndrome).

Contraindications, Precautions, and Warnings

Contraindications:

• Hypersensitivity to Diflunisal.
• History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs (risk of severe anaphylaxis).
• Perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
• Late pregnancy (typically starting at 30 weeks gestation).

GI Safety

Diflunisal causes dose-dependent GI irritation, gastritis, ulceration, and bleeding. Serious GI complications can occur without warning symptoms. Risk is exponentially higher in older adults, patients with a history of peptic ulcers, and those concurrently taking anticoagulants, corticosteroids, SSRIs, or antiplatelet drugs.

Kidney Safety

NSAIDs inhibit renal prostaglandins, which are necessary for maintaining renal blood flow. Diflunisal can cause acute kidney injury, sodium retention, and fluid accumulation. High-risk patients include those with pre-existing chronic kidney disease, heart failure, dehydration, older age, and those taking ACE inhibitors, ARBs, or diuretics.

Cardiovascular Safety

NSAIDs increase the risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke. This risk can occur early in treatment. Diflunisal can also induce new-onset hypertension or worsen existing hypertension. Patients with cardiovascular disease require careful clinical assessment prior to use.

Bleeding Risk & Platelet Function

Diflunisal reversibly inhibits platelet aggregation. Diflunisal is not an aspirin substitute and should not be used as cardiovascular antiplatelet therapy. Concomitant use with antithrombotic drugs (blood thinners) dramatically increases bleeding risk.

Special Populations

Pediatric Use

Safety and effectiveness in pediatric patients (typically under 12 years of age) have not been established. Use is generally not recommended. Never extrapolate adult dosing to children.

Pregnancy

NSAIDs carry significant pregnancy risks. Use at or beyond 30 weeks gestation is strictly contraindicated due to the risk of premature closure of the fetal ductus arteriosus and fetal renal dysfunction (leading to oligohydramnios). Between 20 and 30 weeks, use should be avoided unless absolutely clinically necessary, relying on the lowest dose for the shortest time.

Breastfeeding

Diflunisal is excreted in human breast milk. Due to the potential for serious adverse reactions in nursing infants, a decision must be made whether to discontinue breastfeeding or discontinue the drug, taking into account the importance of the medicine to the mother.

Older Adults

Older adults are highly vulnerable to NSAID toxicity. They face a significantly increased risk of fatal GI bleeding, acute kidney injury, and cardiovascular events. Treatment must follow the lowest effective dose principle, with frequent monitoring of renal function and blood pressure.

Drug–Drug Interactions

Drug / Class	Interaction & Potential Consequence	Recommended Action
Warfarin / Direct Oral Anticoagulants	Synergistic bleeding risk. GI bleeding risk is drastically elevated.	Avoid combination if possible. If necessary, requires extreme clinical monitoring of INR (for warfarin) and bleeding signs.
Aspirin / Other NSAIDs	Increased GI toxicity and bleeding. No therapeutic advantage.	Avoid combination. Do not use Diflunisal with OTC ibuprofen or naproxen.
Corticosteroids	Additive GI mucosal irritation.	Monitor for ulcers/bleeding. May require GI prophylaxis.
ACE Inhibitors / ARBs	Diflunisal may diminish antihypertensive effects and increase acute kidney injury risk.	Monitor blood pressure and renal function closely.
Diuretics	Can reduce the natriuretic effect of diuretics, leading to fluid retention.	Monitor for weight gain, edema, and blood pressure changes.
Lithium	NSAIDs reduce lithium clearance, elevating serum lithium to toxic levels.	Monitor lithium levels frequently and adjust dose if Diflunisal is started/stopped.
Methotrexate	NSAIDs competitively inhibit renal accumulation, increasing methotrexate toxicity.	Requires specialist supervision; monitor for bone marrow suppression and renal toxicity.

Educational Deep Dives

Long Half-Life: Why It Matters

Diflunisal has a relatively long elimination half-life (8 to 12 hours) compared to short-acting NSAIDs like ibuprofen (2 hours).

Clinical Implications:

• Dosing: It allows for twice-daily dosing, improving adherence for chronic arthritis.
• Accumulation: Because clearance takes longer, the drug can accumulate over days, especially in older adults or those with mild renal impairment.
• Adverse Effect Persistence: If an adverse reaction (like GI bleeding or an allergic rash) occurs, the drug remains in the systemic circulation longer after the last dose is taken.

Pharmacy Counselling & Patient Safety Checklist

Pharmacist Checklist Before Dispensing:

• Verify exact indication, dose, and duration.
• Screen for NSAID/aspirin allergies or asthma.
• Check renal, hepatic, and cardiovascular history.
• Perform medication reconciliation (flagging anticoagulants, lithium, MTX, ACEi/ARBs).

Patient Safety Checklist (“Before Taking Diflunisal”):

• ✓ Confirm you are not taking OTC ibuprofen or naproxen.
• ✓ Tell your doctor if you take daily aspirin for your heart.
• ✓ Tell your doctor if you take blood thinners.
• ✓ Tell your doctor if you have kidney disease, high blood pressure, or a history of stomach ulcers.
• ✓ Know the emergency signs: vomiting blood, black stools, chest pain, or sudden swelling.

Clinical Pearls & Common Mistakes

15 High-Value Clinical Pearls:

1. Diflunisal is an NSAID with salicylate-related chemistry, but its pharmacokinetic profile is vastly different from aspirin.
2. It is not the same medicine as aspirin and lacks permanent platelet COX-1 inhibition.
3. It should never be substituted for aspirin’s antiplatelet cardiovascular role.
4. It undergoes capacity-limited pharmacokinetics; as doses increase, half-life prolongs.
5. Enterohepatic recycling contributes heavily to its extended duration of action.
6. GI bleeding is a major NSAID safety concern and can be fatal without prior warning symptoms.
7. Kidney injury occurs via prostaglandin inhibition; dehydration is a massive risk multiplier.
8. Cardiovascular risk (MI, stroke) is a class effect of NSAIDs; use the lowest dose possible.
9. Multiple NSAIDs should generally not be combined without explicit clinical justification.
10. Anticoagulants combined with Diflunisal exponentially increase major bleeding risk.
11. Older adults have decreased renal clearance and thinner gastric mucosa, elevating toxicity risks.
12. Pregnancy requires strict avoidance after 20-30 weeks due to fetal renal and cardiac risks.
13. Pain relief treats symptoms but does not reverse structural osteoarthritis pathology.
14. It lacks a significant antipyretic effect; it is a poor choice for fever management.
15. Lithium and methotrexate levels can fatally rise when combined with NSAIDs.

Common Diflunisal Mistakes to Avoid:

• Confusing it with aspirin: Assuming it offers heart protection.
• “Double dipping”: Taking Diflunisal while also taking OTC cold medicines that contain ibuprofen.
• Ignoring the kidneys: Prescribing standard doses to older adults without checking a basic metabolic panel (eGFR).
• Ignoring blood thinners: Failing to warn patients on warfarin or apixaban about severe bleeding risks.
• Chronic unmonitored use: Continuing the drug indefinitely without reviewing blood pressure and renal function.

Myths vs Facts

• MYTH: “Diflunisal is basically aspirin.”
  • FACT: While chemically related, Diflunisal is a distinct NSAID. It reversibly binds to COX enzymes and lacks aspirin’s permanent platelet inhibition and fever-reducing power.
• MYTH: “Diflunisal can replace low-dose aspirin for heart protection.”
  • FACT: Incorrect. Diflunisal does not permanently disable platelets and actually carries a boxed warning for increasing the risk of heart attacks and strokes.
• MYTH: “All NSAIDs work exactly the same way.”
  • FACT: While they share a mechanism, they differ vastly in half-life, tissue penetration, side effect profiles, and dosing frequency.
• MYTH: “If there is no stomach pain, there is no GI risk.”
  • FACT: Serious, life-threatening GI bleeding and perforation can occur suddenly without any prior warning symptoms like indigestion or pain.
• MYTH: “Longer-lasting pain relief means the medicine is safer.”
  • FACT: A longer half-life means fewer pills per day, but it also means adverse effects (like elevated blood pressure or renal stress) persist longer in the body.
• MYTH: “It’s safe to take with a little bit of ibuprofen.”
  • FACT: Combining NSAIDs drastically increases the risk of bleeding and kidney failure without providing superior pain relief.
• MYTH: “It cures rheumatoid arthritis.”
  • FACT: It only relieves the symptoms (pain and swelling) but does not stop the disease from damaging the joints.
• MYTH: “It is safe at any stage of pregnancy.”
  • FACT: NSAIDs are strictly contraindicated in the third trimester due to severe fetal risks.
• MYTH: “I can double my dose if the pain is severe.”
  • FACT: Exceeding the maximum dose saturates metabolic pathways, spiking toxicity without adding proportional pain relief.
• MYTH: “Taking it with food eliminates the risk of an ulcer.”
  • FACT: Food reduces immediate stomach upset, but NSAID ulcers are largely caused by systemic prostaglandin inhibition in the bloodstream, which food does not prevent.

Patient FAQs

Role-Specific Quick Summaries

Healthcare Professional Section

• Pharmacology: Salicylic acid derivative, reversible COX-1/COX-2 inhibitor. Minimal antipyretic properties.
• Pharmacokinetics: Rapid oral absorption, extensive enterohepatic circulation, non-linear capacity-limited clearance. Half-life 8-12h.
• Safety Profile: Classic NSAID Boxed Warnings apply (GI bleeding/perforation, CV thrombotic events, CABG contraindication).
• Prescribing Note: Dosing for acute pain requires a 1000 mg loading dose to overcome the longer time-to-peak effect compared to propionic acid derivatives. Always reduce dose in renal impairment.

Pharmacy Student Section

• Identity: Salicylate-derived NSAID, structurally modified (difluorophenyl group) for longer half-life and greater potency than plain salicylates.
• Key Exam Points: Differentiate from aspirin (reversible COX inhibition, no CV protective effect). Beware of drug interactions with Lithium (decreased renal clearance), Warfarin (synergistic bleeding), and ACE inhibitors (blunted antihypertensive effect + AKI risk).

Medical Student Section

• Clinical Utility: Good option for bid dosing in OA/RA, but lacks the antipyretic efficacy of ibuprofen/acetaminophen.
• Toxicity Mechanisms: Blocks PGE2/PGI2 in gastric mucosa (ulcers) and afferent arteriole (decreased GFR). Promotes Na+/H2O retention (edema/HTN).
• High-Yield Fact: Because of capacity-limited metabolism, doubling the dose more than doubles the steady-state plasma concentration, steepening the toxicity curve without proportional analgesic gain.

Nursing / Paramedical Section

• Administration: Give with food/milk to reduce acute GI distress. Do not crush.
• Assessment: Screen for concurrent OTC NSAID use. Monitor BP, peripheral edema, and urine output (for AKI).
• Red Flags: Report any new-onset black stools, coffee-ground emesis, sudden weight gain, or dyspnea immediately. Ensure the patient is not taking it if they have upcoming CABG surgery.

Quick Revision Tables

Topic Quick Revision

Topic	Key Point
Drug Class	NSAID (Salicylate derivative)
Mechanism	Reversible COX-1 and COX-2 inhibition
Uses	OA, RA, Acute mild-to-moderate pain
Dosage	500-1000 mg/day (Arthritis); 1000 mg load / 500 mg q12h (Pain)
Half-Life	8-12 hours (allows twice-daily dosing)
Interactions	Warfarin, ACEi, ARBs, Lithium, Methotrexate, other NSAIDs
Aspirin Distinction	Reversible platelet effect; NO cardiovascular protection

NSAID Safety Quick Revision

Risk	Key Point
GI Bleeding	Can occur without warning; fatal risk increases with age/anticoagulants.
Renal Injury	Decreased blood flow to kidneys; massive risk if dehydrated or on ACEi/diuretics.
Cardiovascular	Increases risk of MI/Stroke; Contraindicated in CABG surgery.
Hypertension / Edema	Causes sodium retention; monitor BP routinely.
Pregnancy	Avoid strictly in 3rd trimester (closes fetal ductus arteriosus).

Medical Terminology Glossary

• NSAID: Nonsteroidal Anti-inflammatory Drug.
• Salicylate: A chemical compound related to salicylic acid, often used for pain relief.
• Analgesic: A medicine that reduces or eliminates pain.
• COX (Cyclooxygenase): An enzyme responsible for producing prostaglandins.
• Prostaglandin: Lipids made at sites of tissue damage that cause inflammation, pain, and fever.
• Pharmacokinetics: How the body absorbs, distributes, metabolizes, and excretes a drug.
• Half-life: The time required for the concentration of a drug in the body to reduce by half.
• GI Bleeding: Gastrointestinal bleeding; bleeding in the stomach or intestines.
• Edema: Swelling caused by excess fluid trapped in the body’s tissues.
• Contraindication: A specific situation in which a drug should not be used because it may be harmful.

Combination Products & Storage

Combination Products:

Diflunisal is generally formulated as a single-ingredient product. Always check the active ingredients of any pain medication to avoid duplicate NSAID therapy. Do not assume similar brand names mean identical composition.

Storage:

• Follow product-specific storage instructions.
• Store at room temperature away from light, moisture, and heat (do not store in the bathroom).
• Keep container tightly closed and strictly out of reach of children.
• Do not use damaged or expired medicine.

Related Posts

Propionic Acid Derivatives

Ibuprofen

What Is Ibuprofen? Ibuprofen belongs to a group of medicines called Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Chemically, it is…

Read More→

Salicylates

Salsalate

What Is Salsalate? Salsalate is a prescription medicine used to reduce pain, swelling, and joint stiffness. It belongs…

Read More→

Salicylates

Magnesium Salicylate

What Is Magnesium Salicylate? What is magnesium salicylate? Magnesium salicylate is a pain-relieving (analgesic) and anti-inflammatory medication. It…

Read More→

Salicylates

Choline Salicylate

What Is Choline Salicylate? What is choline salicylate? Choline salicylate is a pain-relieving and anti-inflammatory medicine. It is…

Read More→

Salicylates

Sodium Salicylate

What Is Sodium Salicylate? Sodium salicylate is a medication belonging to the salicylate class of drugs, used to…

Read More→

Salicylates

Aspirin (Acetylsalicylic Acid)

What Is Aspirin? What is aspirin? Aspirin is a medication belonging to the salicylate family used to reduce…

Read More→